bf/NASDAQ:GH_icon.png

NASDAQ:GH

Guardant Health, Inc.

  • Stock

USD

Last Close

96.25

06/11 21:46

Market Cap

3.38B

Beta: 0.81

Volume Today

4.74M

Avg: 1.90M

PE Ratio

−5.81

PFCF: −7.12

    Description

    Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy data...Show More

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52018-03-302019-11-072021-11-042023-11-062024-11-06

    Revenue (Estimate*)

    50M100M150M200M2018-03-302019-11-072021-11-042023-11-062024-11-06

    *Estimate based on analyst consensus